While local and state governments have reaped the revenue benefits legal cannabis has provided, grounds for new legislation continues to grow in popularity while sales in North America reached $6.7 billion in 2016, and that’s without full legislation across the country or in Canada. Funding for the development of grow facilities, as well as advanced CBD-extraction methods, is increasing as momentum continues for Companies such as Future Farm Technologies Inc. (OTC: FFRMF) (CSE:FFT), Aurora Cannabis Inc. (TSX: ACB) (OTC: ACBFF), Agritek Holdings Inc. (OTC: AGTK), InMed Pharmaceuticals Inc. (CSE: IN) (OTC: IMLFF) and Amfil Technologies Inc. (OTC: AMFE)
Future Farm Technologies Inc. (CSE: FFT.CN) (OTCQB: FFRMF) is pleased to announce that it has entered into a Conditional Lease Commitment with Veteran’s Capital Corp, a specialty finance company providing financial and leasing services to various types of business clients (“Veterans Capital”). Veterans Capital has agreed to provide the Company with a secured lease line of credit in an amount not to exceed $500,000.00. The Lease will be secured by the Company’s previously announced cannabis extraction equipment. Read this and more news for Future Farm at: http://www.marketnewsupdates.com/news/ffrmf.html
“We are pleased to have the opportunity to work with Veterans Capital,” says William Gildea, CEO of Future Farm. “Veterans’ line of credit will provide Future Farm with access to capital that will help to expand our cannabis extraction business.”
Future Farm would also like to take this opportunity to announce that a Shareholder Conference Call will be held at 10:00 AM ET on Tuesday, September 19, 2017. Dial-in information will be made available at a later date. The Company invites all Shareholders to attend and to submit questions no later than Friday, September 15th at 5:00 PM ET. Questions may be emailed to firstname.lastname@example.org. Watch the Latest Future Farm Extraction Video at: https://youtu.be/7_BueNu6-5Y
In additional news and developments in the industry this week:
Aurora Cannabis Inc. (TSX: ACB.TO) (OTCQX: ACBFF) came to a close up 2.60% at $1.97 on Monday on over 300,000 shares traded by the market close on OTCQX and up over 2% at $2.51 trading over 900,000 shares on the Toronto Exchange . The company recently announced Nilda Rivera , Nick Whitehead , Dieter MacPherson and Debra Wilson have been appointed as Vice Presidents and Officers of the Company. Nilda Rivera , who has served as Aurora’s Controller and Corporate Secretary since August, 2015, has been promoted to Vice President Finance, reporting to the CFO. Ms. Rivera has more than 20 years of experience in accounting, financial reporting and corporate governance with public companies. As Vice President, Finance, she will be a strategic leader for the Company and be involved in directing operations related to global manufacturing controllership, shared services transaction processing, and corporate accounting.
Agritek Holdings Inc. (OTCQB: AGTK) finished Monday up 17.38% on just over f 5.4 million by the market close. The company recently announced that phase one of construction will begin this month at the 1919 Clinic’s 25,000 square foot cultivation and manufacturing facility located in San Juan, Puerto Rico. Agritek Holdings will provide funding for the build out of the operation, extraction and all equipment as well as cultivation experts under the Agritek team through its executed five (5) year Operations and Licensing Agreement with 1919 Clinic. The Operations and Licensing Agreement entitles Agritek to multiple revenue streams including monthly consulting fees, equipment lease back fees, as well as exclusivity for the sale of Agritek brands including vape products, oils and edibles upon meeting all the standards as set forth for legal operation by the Department of Health for Puerto Rico. l
InMed Pharmaceuticals Inc. (CSE: IN.CN) (OTCQB: IMLFF) closed down slightly on Monday at $0.2132 trading over 1.29 million shares on the OTCQB and up slightly at $0.275 trading over 1.6 Million shares on the Canadian CSE exchange. InMed is a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. InMed conducts research, discovery, preclinical, clinical, regulatory, manufacturing and commercial development activities for its product candidates. InMed’s proprietary bioinformatics database assessment tool, the biosynthesis manufacturing process and its drug development programs are the fundamental value drivers of the Company.
Amfil Technologies Inc. (OTC: AMFE) closed up slightly on Monday on over 2.4 million shares traded by the market close. The company recently announced several updates regarding ongoing developments within the company. The distribution division has been busy fulfilling orders for the 500+ accounts which were newly acquired in July/August. Many new sku’s have been added to our product selection since the beginning of Fiscal Q1 to assist with the further growth and expansion of the distribution division. The company has already completed shipping on the majority of received orders resulting from the recently announced largest sales campaign initiative in company history which kicked off last month. This consisted of over 9,000 orders which have already been fulfilled less than halfway into Fiscal Q1 2018.
DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated twenty-four hundred dollars for news coverage of the current press release issued by Future Farm Technologies Inc by a non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.